Voting Rights Announcements | 16 June 2017 14:39


STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG

16.06.2017 / 14:39
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany

2. Reason for notification
X Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
X Other reason:
Exercise of Instruments

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Morgan Stanley Wilmington, Delaware
United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Morgan Stanley & Co. International plc

5. Date on which threshold was crossed or reached
12 Jun 2017

6. Total positions
% of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in %
(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 5.49 % 1.57 % 7.07 % 62342440
Previous notification 1.85 % 5.53 % 7.37 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in %
direct
(Sec. 21 WpHG)
indirect
(Sec. 22 WpHG)
direct
(Sec. 21 WpHG)
indirect
(Sec. 22 WpHG)
DE0007251803 0 3425106 0.00 % 5.49 %
Total 3425106 5.49 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Call Option From 16.06.2017 to 15.12.2017 at any time 7000 0.01 %
Right of recall over securities lending agreements at any time at any time 800000 1.28 %
Total 807000 1.29 %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Retail Structure Product 28.03.2067 at any time Cash 10160 0.02 %
Equity Swap From 29.09.2017 to 12.03.2020 at any time Cash 160330 0.26 %
Put Option 16.06.2017 at any time Physical 2000 0.003 %
Total 172490 0.28 %

8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Morgan Stanley % % %
Morgan Stanley Capital Management, LLC % % %
Morgan Stanley Domestic Holdings, Inc. % % %
Morgan Stanley Capital Services LLC % % %
% % %
Morgan Stanley % % %
Morgan Stanley Capital Management, LLC % % %
Morgan Stanley Domestic Holdings, Inc. % % %
Morgan Stanley & Co. LLC % % %
% % %
Morgan Stanley % % %
Morgan Stanley International Holdings Inc. % % %
Morgan Stanley International Limited % % %
Morgan Stanley Investments (UK) % % %
Morgan Stanley & Co. International plc 4,14% % % 5,29% %
Morgan Stanley % % %
MSDW Offshore Equity Services Inc. % % %
FUNDLOGIC SAS % % %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:



16.06.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de

End of News DGAP News Service

show this